| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1007.38 | 96 |
| GSM780708 | Untreated after 4 days (C2_1) | 742.031 | 94 |
| GSM780709 | Untreated after 4 days (C3_1) | 544.718 | 92 |
| GSM780719 | Untreated after 4 days (C1_2) | 929.48 | 95 |
| GSM780720 | Untreated after 4 days (C2_2) | 896.655 | 95 |
| GSM780721 | Untreated after 4 days (C3_2) | 650.838 | 93 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 630.768 | 93 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 997.104 | 96 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1013.47 | 96 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 706.646 | 94 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1042.94 | 96 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1154.54 | 96 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 833.155 | 95 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 785.037 | 94 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 911.823 | 95 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1001.68 | 96 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 849.34 | 95 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 929.104 | 95 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1229.67 | 96 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 962.945 | 95 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 871.887 | 95 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1182.51 | 96 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1020.47 | 96 |